 |
The Journal of Neuroscience, February 11, 2004, 24(6):1340-1349; doi:10.1523/JNEUROSCI.4786-03.2004
Previous Article | Next Article 
Neurobiology of Disease
Exacerbation of Motor Neuron Disease by Chronic Stimulation of Innate Immunity in a Mouse Model of Amyotrophic Lateral Sclerosis
Minh Dang Nguyen,1
Thierry D'Aigle,2
Geneviève Gowing,1,2
Jean-Pierre Julien,1,2 and
Serge Rivest2
1McGill University Health Center, Centre for Research in Neurosciences, McGill University, The Montreal General Hospital Research Institute, Montréal, Québec H3G 1A4, Canada, and 2Laboratory of Molecular Endocrinology, Laval University Medical Center Research Center and Department of Anatomy and Physiology, Laval University, Sainte-Foy, Québec G1V 4G2, Canada
Innate immunity is a specific and organized immunological program engaged by peripheral organs and the CNS to maintain homeostasis after stress and injury. In neurodegenerative disorders, its putative deregulation, featured by inflammation and activation of glial cells resulting from inherited mutations or viral/bacterial infections, likely contributes to neuronal death. However, it remains unclear to what extent environmental factors and innate immunity cooperate to modulate the interactions between the neuronal and non-neuronal elements in the perturbed CNS. In the present study, we addressed the effects of acute and chronic administration of lipopolysaccharide (LPS), a Gram-negative bacterial wall component, in a genetic model of neurodegeneration. Transgenic mice expressing a mutant form of the superoxide dismutase 1 (SOD1G37R) linked to familial amyotrophic lateral sclerosis were challenged intraperitoneally with a single nontoxic or repeated injections of LPS (1 mg/kg). At different ages, SOD1G37R mice responded normally to acute endotoxemia. Remarkably, only a chronic challenge with LPS in presymptomatic 6-month-old SOD1G37R mice exacerbated disease progression by 3 weeks and motor axon degeneration. Closely associated with the severity of disease is the stronger and restricted upregulation of the receptor of innate immunity Toll-like receptor 2 and proinflammatory cytokines in degenerating regions of the ventral spinal cord and efferent fiber tracts of the brain from the LPS-treated SOD1G37R mice. This robust immune response was not accompanied by the establishment of acquired immunity. Our results provide solid evidence that environmental factors and innate immunity can cooperate to influence the course of disease of an inherited neuropathology.
Key words: innate immunity; neurodegeneration; lipopolysaccharide; microglia; amyotrophic lateral sclerosis; superoxide dismutase 1; proinflammatory cytokines; transgenic mice
Received July 23, 2003;
revised November 28, 2003;
accepted December 3, 2003.
This article has been cited by other articles:

|
 |

|
 |
 
J. Kang and S. Rivest
MyD88-deficient bone marrow cells accelerate onset and reduce survival in a mouse model of amyotrophic lateral sclerosis
J. Cell Biol.,
December 17, 2007;
179(6):
1219 - 1230.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Koedel, U. M. Merbt, C. Schmidt, B. Angele, B. Popp, H. Wagner, H.-W. Pfister, and C. J. Kirschning
Acute Brain Injury Triggers MyD88-Dependent, TLR2/4-Independent Inflammatory Responses
Am. J. Pathol.,
July 1, 2007;
171(1):
200 - 213.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Urushitani, S. A. Ezzi, and J.-P. Julien
Therapeutic effects of immunization with mutant superoxide dismutase in mice models of amyotrophic lateral sclerosis
PNAS,
February 13, 2007;
104(7):
2495 - 2500.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Davoust, C. Vuaillat, G. Cavillon, C. Domenget, E. Hatterer, A. Bernard, C. Dumontel, P. Jurdic, C. Malcus, C. Confavreux, et al.
Bone marrow CD34+/B220+ progenitors target the inflamed brain and display in vitro differentiation potential toward microglia
FASEB J,
October 1, 2006;
20(12):
2081 - 2092.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D.-C. Wu, D. B. Re, M. Nagai, H. Ischiropoulos, and S. Przedborski
The inflammatory NADPH oxidase enzyme modulates motor neuron degeneration in amyotrophic lateral sclerosis mice
PNAS,
August 8, 2006;
103(32):
12132 - 12137.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Takeshita, T. Tanaka, T. Matsuda, M. Tozuka, K. Kobiyama, S. Saha, K. Matsui, K. J. Ishii, C. Coban, S. Akira, et al.
Toll-Like Receptor Adaptor Molecules Enhance DNA-Raised Adaptive Immune Responses against Influenza and Tumors through Activation of Innate Immunity.
J. Virol.,
July 1, 2006;
80(13):
6218 - 6224.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. P. Turrin and S. Rivest
Tumor Necrosis Factor {alpha} But Not Interleukin 1{beta} Mediates Neuroprotection in Response to Acute Nitric Oxide Excitotoxicity
J. Neurosci.,
January 4, 2006;
26(1):
143 - 151.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Cunningham, D. C. Wilcockson, S. Campion, K. Lunnon, and V. H. Perry
Central and Systemic Endotoxin Challenges Exacerbate the Local Inflammatory Response and Increase Neuronal Death during Chronic Neurodegeneration
J. Neurosci.,
October 5, 2005;
25(40):
9275 - 9284.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Tummala, C. Jung, A. Tiwari, C. M. J. Higgins, L. J. Hayward, and Z. Xu
Inhibition of Chaperone Activity Is a Shared Property of Several Cu,Zn-Superoxide Dismutase Mutants That Cause Amyotrophic Lateral Sclerosis
J. Biol. Chem.,
May 6, 2005;
280(18):
17725 - 17731.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Y. Tanga, N. Nutile-McMenemy, and J. A. DeLeo
The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy
PNAS,
April 19, 2005;
102(16):
5856 - 5861.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. O'Connor, A. Satpathy, M. E. Hartman, E. M. Horvath, K. W. Kelley, R. Dantzer, R. W. Johnson, and G. G. Freund
IL-1{beta}-Mediated Innate Immunity Is Amplified in the db/db Mouse Model of Type 2 Diabetes
J. Immunol.,
April 15, 2005;
174(8):
4991 - 4997.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Arai, T. Furuya, T. Yasuda, M. Miura, Y. Mizuno, and H. Mochizuki
Neurotoxic Effects of Lipopolysaccharide on Nigral Dopaminergic Neurons Are Mediated by Microglial Activation, Interleukin-1{beta}, and Expression of Caspase-11 in Mice
J. Biol. Chem.,
December 3, 2004;
279(49):
51647 - 51653.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. L. Rosenzweig, N. S. Lessov, D. C. Henshall, M. Minami, R. P. Simon, and M. P. Stenzel-Poore
Endotoxin Preconditioning Prevents Cellular Inflammatory Response During Ischemic Neuroprotection in Mice
Stroke,
November 1, 2004;
35(11):
2576 - 2581.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|